Graf Akcie BPMC (Blueprint Medicines Corp). Diskuze k akciím BPMC. Aktuální informace BPMC.

Základní informace o společnosti Blueprint Medicines Corp (Akcie BPMC)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.74B
Hodnota podniku (EV) 5.67B
Tržby 828.095M
EBITDA 345.173M
Zisk 340.152M
Růst v tržbách Q/Q 227.16 %
Růst v tržbách Y/Y 1,001.45 %
P/E (Cena vůči ziskům) 15.96
Forward P/E -0.12
EV/Sales 6.85
EV/EBITDA 16.44
EV/EBIT 16.79
PEG N/A
Price/Sales 6.93
P/FCF 14.09
Price/Book 3.90
Účetní hodnota na akcii 25.65
Hotovost na akcii 15.30
FCF vůči ceně 7.10 %
Počet zaměstnanců 429
Tržba na zaměstnance 1930000
Profit margin 39.54 %
Operating margin 40.90 %
Gross margin 99.95 %
EBIT margin 40.81 %
EBITDA margin 41.68 %
EPS - Zisk na akcii 6.27
EPS - Kvartální růst -18.42 %
EPS - Očekávaný růst příští rok -114.25 %
Return on assets 21.03 %
Return on equity 24.65 %
ROIC 25.42 %
ROCE 23.41 %
Dluhy/Equity 0.17
Čistý dluh/EBITDA -8.04
Current ratio 5.61
Quick Ratio 5.49
Volatilita 3.17
Beta 1.07
RSI 49.98
Cílová cena analytiků 115
Známka akcie (dle analytiků) 1.60
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 58.574M
Procento shortovaných akcií 6.17 %
Short ratio 7.78 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2015
Země United States

Finanční výsledky akcie BPMC

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$793.735$66.512$44.521$21.426$27.772$11.4--
Cost Of Goods Sold$0.425-------
Gross Profit$793.31$66.512$44.521$21.426$27.772$11.4--
Research And Development Expenses$326.86$331.45$243.621$144.687$81.131$48.588$31.844$15.928
SG&A Expenses$157.743$96.388$47.928$27.986$19.218$14.456$7.89$5.072
Other Operating Income Or Expenses--------
Operating Expenses$485.028$427.838$291.549$172.673$100.349$63.044$39.734$21
Operating Income$308.707$-361.326$-247.028$-151.247$-72.577$-51.644$-39.734$-21
Total Non-Operating Income/Expense$6.233$13.632$10.386$3.128$0.082$-1.125$-0.551$0.088
Pre-Tax Income$314.94$-347.694$-236.642$-148.119$-72.495$-52.769$-40.285$-20.912
Income Taxes$1.058-------
Income After Taxes$313.882$-347.694$-236.642$-148.119$-72.495$-52.769$-40.285$-20.912
Other Income--------
Income From Continuous Operations$313.882$-347.694$-236.642$-148.119$-72.495$-52.769$-40.285$-20.912
Income From Discontinued Operations--------
Net Income$313.882$-347.694$-236.642$-148.119$-72.495$-55.922$-46.05$-23.782
EBITDA$315.732$-361.016$-247.163$-149.989$-70.694$-50.696$-39.112$-20.499
EBIT$308.707$-361.326$-247.028$-151.247$-72.577$-51.644$-39.734$-21
Basic Shares Outstanding55484438271811
Shares Outstanding56484438271811
Basic EPS$5.76$-7.27$-5.39$-3.92$-2.64$-3.07$-32.41$-23.43
EPS - Earnings Per Share$5.59$-7.27$-5.39$-3.92$-2.64$-3.07$-32.41$-23.43
# 2020 2019 2018 2017 2016 2015
Current Ratio7.09294.85338.285215.98297.7319.1425
Long-term Debt / Capital--0.02990.02290.01980.0491
Debt/Equity Ratio--0.03080.02860.03490.0784
Gross Margin99.9465100100100100100
Operating Margin38.893-543.2494-554.8573-705.9041-261.3315-453.0176
EBIT Margin38.893-543.2494-554.8573-705.9041-261.3315-453.0176
EBITDA Margin39.778-542.7833-555.1605-700.0327-254.5513-444.7018
Pre-Tax Profit Margin39.6782-522.7538-531.5289-691.305-261.0363-462.886
Net Profit Margin39.5449-522.7538-531.5289-691.305-261.0363-490.5439
Asset Turnover0.46190.0940.08240.02990.09820.0637
Inventory Turnover Ratio0.0495-----
Receiveable Turnover31.36182.8409207.0744-7.7643.3392
Days Sales In Receivables11.6384128.47881.7627-47.0116109.3079
ROE - Return On Equity21.3512-74.8761-56.4766-23.7382-34.0228-36.6505
Return On Tangible Equity21.3512-74.8761-56.4766-23.7382-34.0228-36.6505
ROA - Return On Assets18.266-49.1306-43.8125-20.6946-25.6352-29.4967
ROI - Return On Investment21.3512-74.8761-54.7894-23.1948-33.3482-34.8492
Book Value Per Share25.43679.42449.514914.31856.43295.3196
Operating Cash Flow Per Share12.7034-1.8232-0.8179-2.280.845423.175
Free Cash Flow Per Share12.9401-1.8272-0.6964-2.60481.027523.3999

Porovnání s konkurencí: Akcie BPMC

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BPMC 15.96 N/A 1,001.45 % -114.25 % 24.65 % 3.90 39.54 %
Akcie IMMU N/A N/A N/A % -48.98 % -131.88 % 75.71 N/A %
Akcie OPK 34.18 N/A 97.80 % -125.00 % 4.21 % 1.55 2.13 %
Akcie OPK 34.18 N/A 97.80 % -125.00 % 4.21 % 1.55 2.13 %
Akcie PACB 0.00 N/A 28.24 % 50.00 % -30.77 % 15.25 37.27 %
Akcie PACB 0.00 N/A 28.24 % 50.00 % -30.77 % 15.25 37.27 %

Nedávné obchody insiderů: Akcie BPMC

Jméno Obchod Cena Objem
Marion Dorsch
Chief Scientific Officer
Option
22 Feb 2021
$37.11 $281,220
Kate Haviland
Chief Operating Officer
Option
16 Nov 2020
$36.05 $14,744
Ariel Hurley
Principal Accounting Officer
Prodej
1 Dec 2020
$109.88 $114,055
Mark Alan Goldberg
Director
Option
1 Dec 2020
$28.15 $153,530
Mark Alan Goldberg
Director
Option
11 Dec 2020
$28.15 $153,558
Marion Dorsch
Chief Scientific Officer
Option
14 Dec 2020
$37.11 $170,706
Anthony L. Boral
Chief Medical Officer
Option
14 Dec 2020
$15.01 $150,100
Jeffrey W. Albers
CEO and President
Option
14 Dec 2020
$8.80 $44,000
Charles A Jr Rowland
Director
Option
17 Dec 2020
$19.53 $213,053
Mark Alan Goldberg
Director
Option
18 Dec 2020
$28.15 $153,530
Mark Alan Goldberg
Director
Option
24 Dec 2020
$28.15 $153,558
George Demetri
Director
Prodej
4 Jan 2021
$112.15 $85,010

Diskuze k akciím BPMC